News / Health

    Race On to Develop New Antibiotics

    Carbapenem-resistant Klebsiella pneumoniae bacteria
    Carbapenem-resistant Klebsiella pneumoniae bacteria

    Multimedia

    Vidushi Sinha

    Drug companies are struggling to develop new and more effective antibiotics to combat the growing worldwide threat from drug-resistant germs.  In this second of her 2-part report on "Battling Superbugs," we examine the looming public health danger, and the challenges drug companies face in bringing new antibiotics to market.

    Medical experts watching the rising tide of drug-resistant bacteria have begun sounding the alarms.  They say life-threatening infections could jeopardize surgeries, cancer treatment, organ transplants, and many other specialized medical procedures.

    And some warn that if new anti-microbial drugs are not developed within the next few years, billions of people will be left nearly defenseless against some lethal bacterial infections.

    Such concerns have prompted the Infectious Disease Society of America (IDSA) to call for the development of 10 new antibiotic drugs by the year 2020, an initiative the group calls "10 by 20."

    “The 10 by 20 initiative is IDSA’s challenge to the global community to come together to bring the right group of people together. People in government, industry, academia, policy makers to figure out the right combination of incentives that both will motivate companies who want to develop new antibiotics and also to find new ways to manage these products over time," said Robert Guidos, Vice President of IDSA.

    Experts say that the hour of reckoning has arrived, and that if efforts to combat the problem are not launched now, dangerous diseases eradicated long ago could make a comeback.

    Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, shared that concern recently with Capitol Hill lawmakers. "If we don't improve our response to the public health problem of antibiotic resistance, we may enter a post- antibiotic world in which we will have few or no clinical interventions for some infections," he said.

    Recent studies have shown that there are very few new antibiotics in the development pipeline that would work against lethal infections born out of bacterial resistance such as Methicillin-resistant Staphylococcus aureus, commonly known as MRSA, or carbapenem-resistant Klebsiella pneumoniae, or CRKP for short.

    About 2 million MRSA infections have been reported in U.S. hospitals each year since 2002.

    Barry Eisenstein is Vice President of Cubist, an American drug company with a new anti-MRSA drug in development, as well as many others.

    He says neither the federal regulatory environment nor the pharmaceutical market are favorable for companies trying to develop antibiotics. “The expense and difficulty of doing these...trials for the most important diseases have become very hard and very difficult to the point that many of the big companies have actually gotten out of the field of antibiotic development because they don’t feel that it’s worth the investment," he said.

    Some drug company executives contend that financial returns on investments made in a new antibiotic are significantly lower than for other new drugs reaching the market.

    “Think about the cholesterol-lowering drug - it’s not uncommon for many of the statins to be bringing in $5 - 10 or more billions per year. For an antibiotic to sell at a half a billion is considered a blockbuster, almost unheard of," he said.

    Eisenstein says the push to make "a perfect drug" that is both safe and effective beyond a shadow of doubt has considerably slowed the pace of new antibiotics reaching the market.

    To get companies back in the antibiotics game, Eisenstein says two things have to be done.

    “The regulatory risk - to decrease the great hurdles to get approval and increase the likelihood of being able to get a drug approved in a shorter period of time, at a higher proportion of probability. And then on the economic side, to enable the companies to have greater incentives to overcome what we call market failure," he said.

    Drug companies note that the newest antibiotics, typically, are likely to be prescribed more carefully and used more sparingly - meaning slower sales and smaller profits for the companies that develop them.

    Neverthless, public health experts say one new antibiotic has already been approved for use in the United States, and they are hopeful that the ambitious goal  of developing nine more by 2020 can be achieved.

    You May Like

    Ethiopia's Anti-terrorism Law: Security or Silencing Dissent?

    Yonatan Tesfaye was detained in December 2015 on charges under Ethiopia's Anti-Terrorism Proclamation; eleven statements from his Facebook page were used as evidence

    Egypt Orders Trial for Journalists Charged With Harboring Reporters

    Order targets journalists' union chief Yehia Qalash, Khaled al-Balshy and Gamal Abdel Rahim for allegedly spreading false news, harboring fugitive colleagues

    Nigerian Oil Production Falls as Militant Attacks Take Toll

    Country no longer Africa's petroleum king due to renewed militancy in its oil-producing region

    This forum has been closed.
    Comments
         
    There are no comments in this forum. Be first and add one

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    New Chapter for Tunisia's Ennahdai
    X
    Lisa Schlein
    May 31, 2016 1:56 PM
    Tunisia’s moderate Islamist Ennahda party says it is separating its religious and political activities in a broader bid to mark its so-called Muslim Democratic identity. The move appears to open a new chapter for a party that bounced back from the political wilderness of Tunisia’s pre-revolution days to become a key player in the North African country, and a member of the current coalition government. From Tunis, Lisa Bryant takes a look at how Tunisians are viewing its latest step.
    Video

    Video New Chapter for Tunisia's Ennahda

    Tunisia’s moderate Islamist Ennahda party says it is separating its religious and political activities in a broader bid to mark its so-called Muslim Democratic identity. The move appears to open a new chapter for a party that bounced back from the political wilderness of Tunisia’s pre-revolution days to become a key player in the North African country, and a member of the current coalition government. From Tunis, Lisa Bryant takes a look at how Tunisians are viewing its latest step.
    Video

    Video New Mobile App Allows Dutch Muslims to Rate their Imams

    If a young Dutch-Moroccan app developer has his way, Muslims in the Netherlands will soon be able to rate their imams online. Mohamed Mouman says imams rarely get feedback from their followers. He believes his app can give prayer leaders a better picture of what's happening in their communities — and can also keep young people from being radicalized. Serginho Roosblad reports from Amsterdam.
    Video

    Video Moscow Condemns NATO Plans to Beef Up Defense in Eastern Europe, Baltics

    NATO Secretary General Jens Stoltenberg said Monday an upcoming "landmark summit" will enhance the alliance's defensive and deterrent presence in eastern Europe and the Baltics. He is visiting Poland ahead of the NATO Summit in Warsaw. Zlatica Hoke reports
    Video

    Video Tech Startups Showcase Wares at Amsterdam Conference

    More than 20,000 tech enthusiasts, entrepreneurs and lovers of digital technology came together in Amsterdam recently at the Next Web Conference to discuss the latest developments in digital technology, look to the future and, of course, to connect. In recent years, there has been an explosion of so-called startup businesses that have created devices and applications that have changed the way we live; but, as Serginho Roosblad reports for VOA, there are pitfalls for such startups as well.
    Video

    Video US Military's Fallen Honored With Flags

    Memorial Day is a long weekend for most Americans. For some, it is the unofficial start of summer -- local swimming pools open and outdoor grilling season begins. But Memorial Day remains true to its origins -- a day to remember the U.S. military's fallen.
    Video

    Video Rolling Thunder Rolls Into Washington

    The Rolling Thunder caravan of motorcycles rolled into Washington Sunday, to support the U.S. military on the country's Memorial Day weekend
    Video

    Video A New Reading Program Pairs Kids with Dogs

    Dogs, it is said, are man's best friend. What some researchers have discovered is that they can also be a friend to a struggling reader. A group called Intermountain Therapy Animals trains dogs to help all kinds of kids with reading problems — from those with special needs to those for whom English is a second language. Faiza Elmasry has more on the New York chapter of R.E.A.D., or Reading Education Assistance Dogs, in this piece narrated by Faith Lapidus.
    Video

    Video Fan Base Grows for Fictional Wyoming Sheriff Longmire

    Around the world, the most enduring symbol of the U.S. is that of the cowboy. A very small percentage of Americans live in Western rural areas, and fewer still are cowboys. But the fascination with the American West is kept alive by such cultural offerings as “Longmire,” a series of books and TV episodes about a fictional Wyoming sheriff. VOA’s Greg Flakus recently spoke with Longmire’s creator, Craig Johnson, and filed this report from Houston.
    Video

    Video Chinese-Americans Heart Trump, Bucking National Trend

    A new study conducted by three Asian-American organizations shows there are three times as many Democrats as there are Republicans among Asian-American voters, and they favor Hillary Clinton over Donald Trump. But one group, called Chinese-Americans For Trump, is going against the tide and strongly supports the business tycoon. VOA’s Elizabeth Lee caught up with them at a Trump rally and reports from Anaheim, California.
    Video

    Video Reactions to Trump's Success Polarized Abroad

    What seemed impossible less than a year ago is now almost a certainty. New York real estate mogul Donald Trump has won the number of delegates needed to secure the Republican presidential nomination. The prospect has sparked as much controversy abroad as it has in the United States. Zlatica Hoke has more.
    Video

    Video F-35 Fighter Jet Draws Criticisms as Costs Mount

    America’s latest fighter plane, the F-35, has been mired in controversy. Critics cite cost, faulty design, and the attempt to use it to fill multiple roles. Even the pilot’s helmet is controversial. VOA’s Bernard Shusman reports from New York.
    Video

    Video Concerns Over Civilian Suffering as Iraqi Forces Surround Fallujah

    Thousands of residents are trapped inside the IS-held city ahead of a full scale Iraqi offensive aimed at retaking it.

    Special Report

    Adrift The Invisible African Diaspora